Viewing Study NCT00390793

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-05-05 @ 8:27 AM
Study NCT ID: NCT00390793
Status: COMPLETED
Last Update Posted: 2025-02-17
First Post: 2006-10-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
None BCR-ABL1 Fusion Protein Expression View
None Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
None Philadelphia Chromosome Positive View
None Recurrent Acute Lymphoblastic Leukemia View
None t(9;22) View
Keywords: